Lower-risk Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Lower-risk Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: JSP191 (briquilimab) in Subjects with LR-MDS [Phase 1]
The Phase 1 trial of JSP191 (briquilimab) in patients with lower-risk myelodysplastic syndrome has been terminated.